Browsing by Publisher "Korean Academy of Asthma, Allergy and Clinical Immunology"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Predictive value of the TRACK questionnaire as a measure of asthma control in preschool aged children
    (Korean Academy of Asthma, Allergy and Clinical Immunology, 2014) Yilmaz O.; Turkeli A.; Sahin S.; Yuksel H.
    Assessment of asthma control in preschool children is important for therapeutic decisions. Aim of this study was to evaluate the predictive value of TRACK questionnaire scores for subsequent clinical parameters and to investigate the validity and reliability of the Turkish version of the TRACK questionnaire. We enrolled 100 children with asthma aged 4 years or younger in this cohort study. We recorded sociodemographic characteristics and clinical severity parameters. A pediatric allergist filled in the asthma severity scale and the caregiver of the child filled in the TRACK questionnaire. We called in the children again at the end of one month and recorded the same parameters and administered TRACK again. Uncontrolled asthma was defined as a TRACK score below 80. According to the TRACK score, 65% of the children had controlled asthma initially while at the end of the study 64.1% had controlled asthma. At the beginning of the study, all clinical parameters were worse in children with uncontrolled asthma according to TRACK score. Similarly, other objective clinical parameters during the following one month period were worse in children with initial uncontrolled asthma. Cronbach's alpha score for the TRACK questionnaire was 0.84. Turkish TRACK questionnaire is a valid and reliable tool that is predictive of short term asthma prognosis. © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology.
  • No Thumbnail Available
    Item
    Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing
    (Korean Academy of Asthma, Allergy and Clinical Immunology, 2020) Bousquet J.; Farrell J.; Onorato G.L.; Bedbrook A.; Czarlewski W.; Micheli Y.; Arnavielhe S.; Illario M.; Ansotegui I.J.; Anto J.M.; Bachert C.; Basagaña X.; Bédard A.; Benveniste S.; Bergmann K.C.; Bewick M.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Bosnic-Anticevich S.; Bosse I.; Braido F.; Brussino L.; Camuzat T.; Canonica G.W.; Cardona V.; Carreiro Martins P.; Cecchi L.; Chavannes N.H.; Chu D.K.; Correia da Sousa J.; Costa D.J.; Costa E.; Cruz A.A.; da Silva J.; Devillier P.; de Feo G.; de Vries G.; Dray G.; Ebisawa M.; Erhola M.; Fauquert J.L.; Fokkens W.J.; Fonseca J.; Fontaine J.M.; Gemicioğlu B.; Haahtela T.; Heffler E.; Hellings P.W.; Ivancevich J.C.; Jassem E.; Jutel M.; Kaidashev I.; Kalayci O.; Klimek L.; Kowalski M.L.; Kull I.; Kuna P.; Kvedariene V.; la Grutta S.; Laune D.; Larenas-Linnemann D.; Ierodiakonou D.; Le L.T.T.; Lourenço O.; Makris M.; Menditto E.; Monti R.; Morais-Almeida M.; Münter L.; Muraro A.; Murray R.; Maurer M.; Melén E.; Mösges R.; Mullol J.; Niedoszytko M.; O'Hehir R.E.; Okamoto Y.; Papadopoulos N.G.; Passalacqua G.; Patella V.; Pereira A.M.; Pfaar O.; Pham-Thi N.; Portejoie F.; Price D.; Prokopakis E.P.; Psarros F.; Raciborski F.; Regateiro F.; Reitsma S.; Roche N.; Rolland C.; Ryan D.; Samolinski B.; Sastre J.; Scadding G.K.; Schmid-Grendelmeier P.; Schünemann H.J.; Shamji M.; Sheikh A.; Stellato C.; Suppli-Ulrik C.; Somekh D.; Sova M.; Todo Bom A.; Tomazic P.V.; Toppila-Salmi S.; Triggiani M.; Tsiligianni I.; Valero A.; Valiulis A.; Valovirta E.; van Eerd M.; Vasankari T.; Ventura M.T.; Wallace D.; Waserman S.; Yorgancioglu A.; Zidarn M.; Zuberbier T.
    The reference sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) were renewed in 2019. The DG Santé good practice Mobile Airways Sentinel networK was reviewed to meet the objectives of the EIP on AHA. It included 1) Management of care process, 2) Blueprint of digital transformation, 3) EIP on AHA, innovation to market, 4) Community for monitoring and assessment framework, 5) Political, organizational, technological and financial readiness, 6) Contributing to European co-operation and transferability, 7) Delivering evidence of impact against the triple win approach, 8) Contribution to the European Digital Transformation of Health and Care and 9) scale of demonstration and deployment of innovation. © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.